AURA
NASDAQ · Biotechnology
Aura Biosciences Inc
$6.55
-0.03 (-0.46%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+395.6% upside
Low Target
$26.53
Average Target
$32.46
High Target
$55.40
Current Price
$6.55
Current
$6.55
$6.55
Target
$32.46
$32.46
$26.53
$32.46 avg
$55.40
Scenario Analysis
Bear Case
$26.53
305.0%
Low target
Base Case
$32.46
+395.6%
Avg target
Bull Case
$55.40
+745.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$7.73
-15.3% from high
52-Week Low
$4.35
+50.7% from low
Target vs 52W High
$32.46
+319.9% vs high
Next Earnings Report
Mar 31, 2026 · After Market Close
4d
until earnings
EPS Est: $-0.44
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |